• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Septic Shock (2068)
Event Date 04/12/2016
Event Type  Injury  
Manufacturer Narrative
Pma/510(k) # k163468.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Amelung, 2016: deviating colostomy construction versus stent placement as bridge to surgery for malignant left-sided colonic obstruction.All patients underwent the initial decompression procedure within 48 h after presentation with obstructive symptoms.The gastrointestinal surgeon on call performed the colostomy constructions, while sems placement was performed by one of three expert endoscopists with a minimum of 4-year experience ([20 procedures) with colonic stent placement.Colostomies were constructed on the right transverse colon.An incision was made in the right upper abdominal quadrant; the transverse colon was elevated to the skin, temporarily anchored with a plastic rod and fixed with resolvable stitches.Four different stent types were used, based on availability, i.E., wallstent _ (boston scientific, natrick, ma, usa), wallflex_ (boston scientific), ultraflex_ (boston scientific) and evolution_ (cook medical, limerick, ireland).After colostomy construction or stent placement, patients received enteral feeding as soon as possible.Elective resection was performed after approximately 2¿4 weeks.Perforation due to stent placement (n = 1).Patient outcome: require intervention/additional procedures s=4.Patient/event info - notes: as per fda guidance: average patient age and weight, as well as the gender of the majority of patients involved/individual patient info if available.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation on 20-may-2024.
 
Manufacturer Narrative
Pma/510(k) # k163468.Device evaluation: the 01x evolution® colonic controlled-release stent - uncovered device of unknown lot number and rpn involved in this complaint was not available for evaluation.With the information provided, a document-based investigation was conducted.This file was created in response to the journal article ¿amelung 2016 - deviating colostomy construction versus stent placement as bridge to surgery for malignant left-sided colonic obstruction¿ to capture 01x cases of perforation due to stent placement.The following were also raised in response to this pmcf study/journal article: ¿ pr (b)(4) ¿ ¿amelung 2016 ¿ stent obstruction caused by fecal debris¿ ¿ pr (b)(4) ¿ ¿amelung 2016 ¿ stent migration¿ the device lab evaluation could not be completed as the device, or photographic evidence of the device, was not returned for evaluation.Manufacturing records review: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.Manufacturing records review could not be completed as the lot number is unknown.Instructions for use and/label review: as per the ifu (ifu0052), perforation and septicaemia are both known potential adverse event associated with gi endoscopy ¿those associated with gi endoscopy include, but are not limited to: perforation, hemorrhage, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest.¿ ¿additional adverse events include, but are not limited to: intestinal perforation, pain, inadequate stent expansion, stent misplacement and/or migration, tumour ingrowth or overgrowth, stent occlusion, ulcerations, pressure necrosis, erosion of the luminal mucosa, septicemia, foreign body sensation, bowel impaction, diarrhea, constipation, peritonitis, symptoms of tenesmus or urgency/incontinence, death (other than due to normal disease progression)." there is no evidence to suggest that the customer did not follow the instructions for use or product label.Image review: an image was not returned for evaluation.Root cause analysis: a definitive root cause could not be determined from the available information.A possible root cause could be attributed to known procedural adverse events and/or patients pre-existing conditions.According to the medical advisor's input, both intestinal perforation and septicemia in this study can be possibly root caused to the stent, the stent placement procedure and/or the patient's pre-existing conditions.As mentioned above, both perforation and septicaemia are listed as known adverse events listed within the instruction's for use "potential complications" section.Confirmation of complaint: complaint is confirmed based on customer and/or rep testimony.Confirmed quantity of 01x used devices.Summary of investigation: according to the journal article, the patient did experience adverse effects due to this occurrence.Regarding the patient mortality in the study, as per clinical input, ¿one 30-day mortality occurred in sems group due to an abdominal sepsis secondary to a perforation occurred in one patient treated with sems.It was impossible to determine which stent was being used.Again, the type of the perforation and if the perforation caused direct patient¿s death were unknown.¿ therefore, it is not definitive that the cook evolution colonic stents listed in this journal article caused or contributed to the mortality documented.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key18443462
MDR Text Key331881923
Report Number3001845648-2024-00001
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other
Type of Report Initial
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/12/2016
Event Location Hospital
Initial Date Manufacturer Received 12/08/2023
Initial Date FDA Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexFemale
-
-